The Bangladesh pharmaceutical market is grow- ing rapidly and has almost doubled over the last five years. Bangladesh pharmaceutical industry is dominated by the local pharma
companies and they hold the major market share. The
local manufacturers are mainly involved in the production of generic drugs, thus the generic drugs rule the
Bangladesh pharma market. Bangladesh is emerging as
a potential pharma hub as the pharma companies are
investing in developing their new state of art manufacturing facilities for producing quality drugs for exporting
to the developed nations. This article will discuss about
the booming potential, strength & weakness, regulations,
export strength and position of MNCs in Bangladesh
The Bangladesh pharma industry contributes to 1% of
GDP and it is the third largest tax paying industry in the
country. The main focus of pharmaceutical firms is on
branded generic final formulations using imported APIs. The
pharmaceutical market in Bangladesh is insignificant when
compared to the population size as they lack spending
power. The total healthcare expenditures accounts to just
3. 4 percent of GDP.
The pharmaceutical industry has made significant progress after the enactment of the National Drug Policy in 1982.
Ever year pharmaceutical export is increasing at a higher
pace, contributing prominently to the GDP of the country.
Pharma sector is the second largest potential sector in
terms of foreign currency for Bangladesh.
Pharma CMOs in Bangladesh
Looking beyond Indo-China
By Saranraj Sivabushnam, Beroe Consulting